Platelet reactivity and pregnancy loss

Objective We sought to critically evaluate platelet function in recurrent miscarriage (RM). Study Design We conducted a prospective study comparing 30 patients with unexplained recurrent first-trimester pregnancy loss with 30 control subjects matched for age and serum progesterone level. Platelet fu...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of obstetrics and gynecology 2010-09, Vol.203 (3), p.281.e1-281.e5
Main Authors:	Flood, Karen, MD, Peace, Aaron, PhD, Kent, Etaoin, MD, Tedesco, Tony, MD, Dicker, Patrick, PhD, Geary, Michael, MD, Malone, Fergal D., MD, Kenny, Dermot, MD
Format:	Article
Language:	eng
Subjects:	Abortion, Habitual - blood Adenosine Diphosphate - pharmacology Adult arachidonic acid Arachidonic Acid - pharmacology Biological and medical sciences Case-Control Studies Collagen Type I - pharmacology Diseases of mother, fetus and pregnancy Dose-Response Relationship, Drug Epinephrine - pharmacology Female Gynecology. Andrology. Obstetrics Humans Medical sciences Middle Aged Obstetrics and Gynecology Peptide Fragments - pharmacology Platelet Aggregation - drug effects Platelet Function Tests platelet reactivity Pregnancy Pregnancy Trimester, First Pregnancy. Fetus. Placenta Prospective Studies recurrent miscarriage
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Objective We sought to critically evaluate platelet function in recurrent miscarriage (RM). Study Design We conducted a prospective study comparing 30 patients with unexplained recurrent first-trimester pregnancy loss with 30 control subjects matched for age and serum progesterone level. Platelet function was determined using a modified assay of light transmission aggregometry with multiple agonists at different concentrations. Dose-response curves were created and half-maximal effective concentration values were calculated. Results At test completion the half-maximal effective concentration values for arachidonic acid in the patients with RM were significantly less than in the control subjects (0.153 vs 0.230; P = .0099). The dose-response curves were tightly matched for the other agonists. Conclusion This novel measurement of platelet function has demonstrated that patients with unexplained RM have significantly increased platelet aggregation in response to arachidonic acid. The enhanced response to this agonist provides an empirical rationale for the use of aspirin in management of this clinical condition.
ISSN:	0002-9378 1097-6868